JP2013529679A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529679A5
JP2013529679A5 JP2013517669A JP2013517669A JP2013529679A5 JP 2013529679 A5 JP2013529679 A5 JP 2013529679A5 JP 2013517669 A JP2013517669 A JP 2013517669A JP 2013517669 A JP2013517669 A JP 2013517669A JP 2013529679 A5 JP2013529679 A5 JP 2013529679A5
Authority
JP
Japan
Prior art keywords
xylitol
injectable pharmaceutical
agent
pharmaceutical formulation
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013517669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529679A (ja
Filing date
Publication date
Priority claimed from IL206739A external-priority patent/IL206739A/en
Application filed filed Critical
Publication of JP2013529679A publication Critical patent/JP2013529679A/ja
Publication of JP2013529679A5 publication Critical patent/JP2013529679A5/ja
Pending legal-status Critical Current

Links

JP2013517669A 2010-06-30 2011-06-15 関節の処置のための注射用医薬組成物 Pending JP2013529679A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL206739A IL206739A (en) 2010-06-30 2010-06-30 An injectable drug containing silitol as an active substance
IL206739 2010-06-30
PCT/IL2011/000495 WO2012001679A1 (en) 2010-06-30 2011-06-15 Injectable pharmaceutical compositions for the treatment of joints

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016063344A Division JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Publications (2)

Publication Number Publication Date
JP2013529679A JP2013529679A (ja) 2013-07-22
JP2013529679A5 true JP2013529679A5 (enExample) 2014-07-17

Family

ID=43569968

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013517669A Pending JP2013529679A (ja) 2010-06-30 2011-06-15 関節の処置のための注射用医薬組成物
JP2016063344A Expired - Fee Related JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016063344A Expired - Fee Related JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Country Status (9)

Country Link
US (2) US9913808B2 (enExample)
EP (1) EP2588080B1 (enExample)
JP (2) JP2013529679A (enExample)
KR (1) KR101842295B1 (enExample)
CA (1) CA2803257C (enExample)
ES (1) ES2679279T3 (enExample)
HU (1) HUE039724T2 (enExample)
IL (1) IL206739A (enExample)
WO (1) WO2012001679A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
WO2017069822A2 (en) * 2015-07-20 2017-04-27 The Brigham And Women's Hospital, Inc. Shear-thinning compositions as an intravascular embolic agent
BR112020003767B1 (pt) 2017-08-22 2023-10-10 Moebius Medical Ltd Composição farmacêutica que compreende lipossomas e uso da dita composição para tratar dor ou irritação em uma articulação
JP7350344B2 (ja) * 2018-06-25 2023-09-26 イップスセル インコーポレイテッド ヒト誘導万能幹細胞から軟骨細胞のペレットを製造する方法およびその用途
JPWO2022168968A1 (enExample) * 2021-02-05 2022-08-11
CA3266614A1 (en) 2023-01-19 2024-07-25 Moebius Medical Ltd. LONG-ACTING LIPOSOMAL COMPOSITION FOR THE TREATMENT OF PAIN IN JOINT DISORDERS

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767785A (en) 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
JP2788340B2 (ja) * 1989-12-21 1998-08-20 株式会社ニッショー 炎症治療剤
US5095037B1 (en) * 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
AUPM922394A0 (en) * 1994-11-03 1994-11-24 Astra Pharmaceuticals Pty Ltd Plastic syringe with overcap
ES2232839T3 (es) 1995-08-07 2005-06-01 Suntory Limited Uso de una composicion para prevenir o tratar enfermedades causadas por anormalidades en tejidos cartilaginosos.
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
EP1092447B1 (en) * 1999-10-14 2004-01-07 Becton Dickinson and Company Nasal delivery device including spray nozzle
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
FR2833173B1 (fr) 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
BRPI0415531B8 (pt) * 2003-10-23 2021-05-25 Otsuka Pharma Co Ltd formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
CN101505746A (zh) * 2005-06-17 2009-08-12 迪纳米斯治疗公司 炎症的治疗方法
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
CN101209344B (zh) * 2006-12-28 2012-07-04 赵超英 高渗液组合物在制备促进伤口愈合的药物中的应用
CN101450037A (zh) * 2007-11-28 2009-06-10 天津太平洋制药有限公司 一种木糖醇静脉注射液及其制备方法
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
CN101664384B (zh) * 2009-09-18 2011-09-14 杭州市第六人民医院 N-乙酰半胱氨酸盐木糖醇注射液及其制备方法和应用
CN101669962A (zh) * 2009-09-18 2010-03-17 杭州市第六人民医院 复合甘草酸氨基酸注射液及其制备方法和应用
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
WO2012143876A1 (en) 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint

Similar Documents

Publication Publication Date Title
JP2014505733A5 (enExample)
JP2016512248A5 (enExample)
JP2014240439A5 (enExample)
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP2012012418A5 (enExample)
HRP20250200T1 (hr) Farmaceutski pripravci koji sadrže meloksikam
BR112014011504A2 (pt) forma de dosagem farmacêutica oral inviolável compreendendo ingrediente farmacologicamente ativo, antagonista opioide e/ou agente aversivo, óxido de polialquileno e polímero aniônico
HRP20221294T1 (hr) Neuroaktivni steroidi, njihovi pripravci i uporabe
BR112017006957A2 (pt) formulações farmacêuticas para a liberação por via oral de fármacos do tipo de peptídeo ou proteína
RU2018135967A (ru) Интраназальные фармацевтические композиции на основе бензодиазепина
JP2011521969A5 (enExample)
MX382192B (es) Composiciones de canabinoide y usos.
BR112015017246A8 (pt) composição farmacêutica aquosa, seu uso e seringa
IN2014DN10673A (enExample)
AR068816A1 (es) Composiciones de brimonidina mejorada para el tratamiento del eritema
WO2011126839A3 (en) Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
WO2014127016A3 (en) Ultrapure tetrahydrocannabinol-11-oic acids
MX2014008283A (es) Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
WO2015116856A3 (en) Farnesoid x receptor antagonists
RU2011136636A (ru) Фармацевтическая композиция для орального введения
WO2013022243A3 (ko) 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
WO2015019304A3 (fr) Compositions à libération continue à base d'acide hyaluronique, et leurs applications thérapeutiques
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
RS52620B (sr) Upotreba hitosana za lečenje inflamatornih bolesti noktiju